Evidence map›Paper›PMID 39848914›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2025

Nephrectomy in autosomal dominant polycystic kidney disease: a consensus statement of the ERA Genes & Kidney Working Group.

Paul Geertsema, Ron T Gansevoort, Mustafa Arici, Giovambattista Capasso, Emilie Cornec-Le Gall, Monica Furlano, Daniel G Fuster, Flavia Galletti, Victoria Gómez Dos Santos, Maria Vanessa Perez Gomez and 16 more

Abstract readConsensus Statement
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. KDIGO 2025 ADPKD guideline: a commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Paul GeertsemaD epartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0003-1376-9727
Ron T GansevoortD epartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Mustafa AriciDepartment of Nephrology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Giovambattista CapassoDepartment of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.ORCID 0000-0003-3469-8614
Emilie Cornec-Le GallUniversity of Brest, Inserm, Unité Mixte de Recherche 1078, Génétique, Génomique fonctionnelle et Biotechnologies, Centre Hospitalier Universitaire Brest, Centre de Références Maladies Rénales Héréditaires de l'Adulte et de l'Enfant MARHEA, Brest, France.ORCID 0000-0003-1958-4459
Monica FurlanoNephrology Department, Fundació Puigvert; Institut de Recerca Sant Pau (IR Sant Pau); Departament de Medicina, Universitat Autónoma de Barcelona, Barcelona, Spain.
Daniel G FusterDepartment of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID 0000-0001-7220-1803
Flavia GallettiPKD International, Geneva, Switzerland.
Victoria Gómez Dos SantosDepartment of Urology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), University of Alcalá, Madrid, Spain.
Maria Vanessa Perez GomezDepartment of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.ORCID 0000-0003-4558-5236
Dimitrios GoumenosDepartment of Nephrology and Renal Transplantation, University Hospital of Patras, Patras, Greece.
Jan HalbritterDepartment of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Eva JambonDepartment of Diagnostic and Interventional Radiology, Pellegrin University Hospital, Bordeaux, France.
Uwe KorstPKD International, Geneva, Switzerland.
Anna M Leliveld-KorsDepartment of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-7028-0824
Mireia MusqueraDepartment of Urology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Arnaldo FigueiredoDepartment of Urology and Renal Transplantation, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Tom NijenhuisDepartment of Nephrology, Research Institute of Medical Innovations, Radboud University Medical Centre, Nijmegen, The Netherlands.ORCID 0000-0002-4375-7236
Jonathon OlsburghDepartment of Urology & Transplant Surgery, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Robert A PolDepartment of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-2236-5233
John A SayerBioscience Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Renal Services, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Dirk StippelDepartment of General, Visceral, Cancer and Transplant Surgery, University Hospital Cologne, Köln, Germany.
Roser TorraNephrology Department, Fundació Puigvert; Institut de Recerca Sant Pau (IR Sant Pau); Departament de Medicina, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0001-8714-2332
Roman-Ulrich MüllerDepartment II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID 0000-0001-6910-0745
Niek F CasteleijnDepartment of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
members of the study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A substantial number of patients with autosomal dominant polycystic kidney disease (ADPKD) undergo a nephrectomy, especially in workup for a kidney transplantation. Currently, there is no evidence-based algorithm to guide clinicians about which patients should undergo nephrectomy, the optimal timing of this procedure, or the preferred surgical technique. This systematic review-based consensus statement aimed to answer important questions regarding nephrectomy in ADPKD. A literature review was performed and extended to a meta-analysis when possible. For this purpose, PubMed and EMBASE were searched up to May 2024. Fifty-four publications, describing a total of 2391 procedures, were included. In addition, an exploratory questionnaire was sent to urologists, nephrologists, and transplant surgeons. These sources were used to develop practice points about indications, complications, mortality, and timing and technique of nephrectomy. In addition, data on renal embolization as a potential alternative to nephrectomy were explored and summarized. To reach consensus, practice points were defined and improved in three Delphi survey rounds by experts of the European Renal Association Working Group Genes & Kidney and the European Association of Urology Section of Transplantation Urology. A total of 23 practice points/statements were developed, all of which reached consensus. Among others, it was deemed that nephrectomy can be performed successfully for various indications and is an intermediate risk procedure with acceptable mortality and minimal impact on kidney graft function when performed before, in the same session or after transplantation. The complication rate seems to increase when the procedure is performed as an emergency. During the workup for transplantation, patient complaints should be assessed routinely by questionnaires to indicate symptom burden. Deciding on the need for nephrectomy and exploring potential alternatives such as kidney embolization should be a process of shared decision-making, preferably after multidisciplinary consultation.

Indexed as

ConsensusNephrectomyPolycystic Kidney, Autosomal DominantHumansKidney TransplantationSystematic Reviews as TopicADPKDkidney transplantationnephrectomypolycystic kidney disease

Identifiers

PMID39848914
PMCPMC12209818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.